GHRP-6Understand the science
How a 2026 experiment studied cardiac remodeling after a blocked artery
2 numbered sourcesSource years 2021, 2026
Peptides are short amino-acid chains connected by peptide bonds. Some act as signals that researchers can use to probe responses in specific tissues. GHRP-6, short for growth hormone–releasing peptide 6, is a six-residue peptide that activates the ghrelin receptor. In March 2026 researchers reported what happened when they studied GHRP-6 after a coronary artery was permanently blocked in rats. [1, 2]
When part of the heart loses its blood supply, muscle can be damaged and the shape and function of the heart can change. This process is called remodeling. In the study, researchers tied off a coronary artery in rats to produce an injury that would persist without restored blood flow. They compared injured animals exposed to GHRP-6 with injured rats given a control solution. A sham-operated group provided a reference for changes associated with the artery blockage. [1]
After seven days, the researchers examined hearts with ultrasound and by studying tissue samples. The rats exposed to GHRP-6 had less scarring between heart muscle fibers and improvements in measurements of the left ventricle compared with the injured controls. The left ventricle is the main pumping chamber that sends blood to the body. Ultrasound measurements describe function in the living animal. Examination under the microscope describes structural changes in sampled tissue. The two measurements make related observations without measuring exactly the same thing. [1]
The paper also examined mitochondrial proteins in a separate experiment using healthy rats. Mitochondria help cells turn nutrients into usable energy. The researchers found changes in proteins associated with energy metabolism, stress responses and cell survival. These findings gave them ideas about what could contribute to the heart results. Because the proteins were measured in healthy animals, the experiment did not directly establish which of those changes caused the differences observed in the injured animals. [1]
This recent study tested GHRP-6 alone, an important distinction from stroke experiments where it was combined with another compound. It describes a short-term effect under conditions of a permanently blocked artery in rats. It leaves open whether any signal would persist, appear in an injury model where blood flow was restored, or occur in people. Those questions involve different comparisons and time frames. The tissue and ultrasound findings are evidence about how the experimental rats responded. They do not establish a human cardiac treatment or a human benefit. [1]
Sources
Original works cited in this article. Links open the external record in a new tab.
